San Marcos, CA, United States of America

Mark E Filipowsky

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mark E Filipowsky: Innovator in Nucleic Acid Deactivation

Introduction

Mark E Filipowsky is a notable inventor based in San Marcos, California. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid deactivation. With a total of two patents to his name, Filipowsky's work has the potential to impact various applications in research and diagnostics.

Latest Patents

Filipowsky's latest patents include "Solutions, methods and kits for deactivating nucleic acids" and "Method of making a formulation for deactivating nucleic acids." Both inventions relate to reagents designed for the deactivation of nucleic acids, providing methods for making and utilizing these reagents effectively. These innovations are crucial for ensuring the safety and efficacy of nucleic acid-based applications.

Career Highlights

Mark E Filipowsky is currently employed at Gen-Probe, Inc., a company known for its advancements in molecular diagnostics. His work at Gen-Probe has allowed him to further develop his inventions and contribute to the company's mission of improving healthcare through innovative technologies.

Collaborations

Filipowsky has collaborated with notable colleagues, including Norman C Nelson and Kenneth A Browne. These partnerships have likely enhanced the development and application of his inventions, fostering a collaborative environment for innovation.

Conclusion

Mark E Filipowsky is a distinguished inventor whose work in nucleic acid deactivation is paving the way for advancements in molecular biology. His contributions through patents and collaborations highlight his commitment to innovation in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…